Growth Metrics

OmniAb (OABI) Other Non Operating Income (2023 - 2026)

OmniAb (OABI) reported Other Non Operating Income of $77000.0 for Q1 2026, up 7600.0% year-over-year from $1000.0 in Q1 2025, and up 1640.0% on a QoQ basis from -$5000.0 in Q4 2025.

OmniAb (OABI) has 4 years of Other Non Operating Income data on file, last reported at $77000.0 in Q1 2026.

  • Quarterly Other Non Operating Income rose 7600.0% year-over-year to $77000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $91000.0 (up 750.0% YoY) and the FY2025 annual result came in at $15000.0, up 200.0% from the prior year.
  • Other Non Operating Income grew to $77000.0 in Q1 2026 per OABI's latest filing, from -$5000.0 in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $77000.0 in Q1 2026 and bottomed at -$9000.0 in Q2 2024.
  • The 4-year median for Other Non Operating Income is -$3000.0 (2023), against an average of $7090.9.
  • The widest annual swing landed in 2025, when Other Non Operating Income plunged 350.0%; it then soared 7600.0% in 2026.
  • Tracing OABI's Other Non Operating Income over 4 years: stood at -$3000.0 in 2023, then surged by 166.67% to $2000.0 in 2024, then sank by 350.0% to -$5000.0 in 2025, then jumped by 1640.0% to $77000.0 in 2026.
  • Per Business Quant, the three latest OABI Other Non Operating Income figures stand at $77000.0 (Q1 2026), -$5000.0 (Q4 2025), and -$8000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 OmniAb 334.72 Mn 291.75 Mn 14.41 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 77,000.00
Dec 31, 2025 -5,000.00
Sep 30, 2025 -8,000.00
Jun 30, 2025 27,000.00
Mar 31, 2025 1,000.00
Dec 31, 2024 2,000.00
Sep 30, 2024 -8,000.00
Jun 30, 2024 -9,000.00
Dec 31, 2023 -3,000.00
Sep 30, 2023 8,000.00
Jun 30, 2023 -4,000.00